Skip to content

The prognostic effect of immunonutritional therapy on postoperative adjuvant chemotherapy patients with driver gene negative non-small cell lung cancer

The prognostic effect of immunonutritional therapy on postoperative adjuvant chemotherapy patients with driver gene negative non-small cell lung cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092138
Enrollment
Unknown
Registered
2024-11-11
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

driver gene negative non-small cell lung cancer

Interventions

Immunonutrition (IM):The IM group was given an enteral nutrition preparation containing three major immunonutrients: nucleotides, omega-3 fatty acids, and arginine (SuYiSu tumor type full nutrition sp
Con:The Con group is given a standard nutritional formula with equal calories (Kangsu Deshu Shan Full Nutritional Special Medical Purpose Formula Food, product description and special medical certific

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis of non-small cell lung cancer in patients who plan to receive chemotherapy after sleeve surgery; Genetic testing showed no EGFR, ALK, or ROS1 mutations; 2. patients aged = 18 years old; 3. Three patients who are not allergic to the ingredients of the special medical formula food used in the research institute; 4. All four patients signed informed consent forms;

Exclusion criteria

Exclusion criteria: 1. Patients deemed unsuitable for inclusion in the study by the researcher; 2. Two patients who are allergic to the ingredients of special medical formula foods used in the research institute; 3. Three patients with severe sepsis.

Design outcomes

Primary

MeasureTime frame
nutritional status;

Secondary

MeasureTime frame
Quality of life (QLQ-C30) assessed ;

Countries

China

Contacts

Public ContactQin Ding

Shanghai Pulmonary Hospital

15026961887@sina.cn+86 150 2696 1887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026